FI935409L - Orgaanisiin yhdisteisiin liittyviä parannuksia - Google Patents

Orgaanisiin yhdisteisiin liittyviä parannuksia Download PDF

Info

Publication number
FI935409L
FI935409L FI935409A FI935409A FI935409L FI 935409 L FI935409 L FI 935409L FI 935409 A FI935409 A FI 935409A FI 935409 A FI935409 A FI 935409A FI 935409 L FI935409 L FI 935409L
Authority
FI
Finland
Prior art keywords
organic compounds
improvements related
compounds
organic
Prior art date
Application number
FI935409A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI935409A7 (fi
FI935409A0 (fi
Inventor
Michael Morris Dreyfuss
Albert Leutwiler
Andrew Roland Mckenzie
Joerg Schnyder
Rene Paul Traber
Henri Mattes
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI935409A0 publication Critical patent/FI935409A0/fi
Publication of FI935409A7 publication Critical patent/FI935409A7/fi
Publication of FI935409L publication Critical patent/FI935409L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/145—Fungi isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/08—Oxygen as only ring hetero atoms containing a hetero ring of at least seven ring members, e.g. zearalenone, macrolide aglycons
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Pain & Pain Management (AREA)
  • Botany (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dermatology (AREA)
  • Vascular Medicine (AREA)
  • Mycology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
FI935409A 1992-12-04 1993-12-02 Orgaanisiin yhdisteisiin liittyviä parannuksia FI935409L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB929225396A GB9225396D0 (en) 1992-12-04 1992-12-04 Improvements in or relating to organic compounds

Publications (3)

Publication Number Publication Date
FI935409A0 FI935409A0 (fi) 1993-12-02
FI935409A7 FI935409A7 (fi) 1994-06-05
FI935409L true FI935409L (fi) 1994-06-05

Family

ID=10726140

Family Applications (1)

Application Number Title Priority Date Filing Date
FI935409A FI935409L (fi) 1992-12-04 1993-12-02 Orgaanisiin yhdisteisiin liittyviä parannuksia

Country Status (18)

Country Link
EP (1) EP0606044A1 (enExample)
JP (1) JPH06228122A (enExample)
KR (1) KR940014377A (enExample)
CN (1) CN1095417A (enExample)
AU (1) AU5211293A (enExample)
CA (1) CA2110553A1 (enExample)
CZ (1) CZ261493A3 (enExample)
FI (1) FI935409L (enExample)
GB (1) GB9225396D0 (enExample)
HU (1) HUT65910A (enExample)
IL (1) IL107838A0 (enExample)
MX (1) MX9307608A (enExample)
NO (1) NO934372L (enExample)
NZ (1) NZ250344A (enExample)
PL (1) PL301281A1 (enExample)
SK (1) SK135493A3 (enExample)
TW (1) TW258736B (enExample)
ZA (1) ZA939088B (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4228328C2 (de) * 1992-08-26 1999-02-11 Agie Sa Maschine und Verfahren zum funkenerosiven Drahtschneiden mit einer im Querschnitt verformten Drahtelektrode
US5795910A (en) * 1994-10-28 1998-08-18 Cor Therapeutics, Inc. Method and compositions for inhibiting protein kinases
US5731343A (en) * 1995-02-24 1998-03-24 The Scripps Research Institute Method of use of radicicol for treatment of immunopathological disorders
ES2149468T3 (es) * 1995-04-26 2000-11-01 Kyowa Hakko Kogyo Kk Derivados de radicicol.
AU779438B2 (en) * 1998-12-24 2005-01-27 Novation Pharmaceuticals Inc. Compounds which affect mRNA stability and uses therefor
ATE328888T1 (de) 2000-08-25 2006-06-15 Sloan Kettering Inst Cancer Radicicol und monocillin und ihre analogen und ihre anwendungen
JP2004292314A (ja) * 2000-12-14 2004-10-21 Chugai Pharmaceut Co Ltd ケラチノサイト増殖抑制剤
JP2004292315A (ja) * 2000-12-14 2004-10-21 Chugai Pharmaceut Co Ltd Tak1阻害剤
GB0112522D0 (en) * 2001-05-23 2001-07-11 Ici Plc Catalytic process
CA2478065C (en) * 2002-03-08 2013-01-08 Eisai Co. Ltd. Macrocyclic compounds useful as pharmaceuticals
US7915306B2 (en) 2002-03-08 2011-03-29 Eisai Co., Ltd. Macrocyclic compounds useful as pharmaceuticals
RU2312863C2 (ru) * 2002-04-17 2007-12-20 Тайсо Фармасьютикал Ко., Лтд. Тоник для роста волос
US20060079494A1 (en) * 2004-09-27 2006-04-13 Santi Daniel V Specific kinase inhibitors
US7601852B2 (en) 2006-05-11 2009-10-13 Kosan Biosciences Incorporated Macrocyclic kinase inhibitors
CN105748465A (zh) 2007-07-25 2016-07-13 卫材R&D管理株式会社 用于治疗癌症的多激酶抑制剂
EP2453234B1 (en) 2007-10-29 2014-01-15 Eisai R&D Management Co., Ltd. Methods for prognosing the ability of a zearalenone analog compound to treat cancer
MX2010005999A (es) 2007-12-07 2010-06-23 Eisai R&D Man Co Ltd Intermediarios en la sintesis de analogos de macrolidos de zearalenona.
AU2009303389B2 (en) 2008-10-17 2014-10-16 Wisconsin Alumni Research Foundation Method of making biologically active alpha-beta peptides

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3196019A (en) * 1964-04-06 1965-07-20 Purdue Research Foundation Anabolic and estrogenic compound and process of making

Also Published As

Publication number Publication date
NO934372D0 (no) 1993-12-02
SK135493A3 (en) 1994-08-10
FI935409A7 (fi) 1994-06-05
FI935409A0 (fi) 1993-12-02
MX9307608A (es) 1995-01-31
IL107838A0 (en) 1994-04-12
NO934372L (no) 1994-06-06
PL301281A1 (en) 1994-06-13
JPH06228122A (ja) 1994-08-16
CZ261493A3 (en) 1994-07-13
HUT65910A (en) 1994-07-28
KR940014377A (ko) 1994-07-18
ZA939088B (en) 1995-06-05
HU9303444D0 (en) 1994-04-28
NZ250344A (en) 1995-10-26
CN1095417A (zh) 1994-11-23
CA2110553A1 (en) 1994-06-05
AU5211293A (en) 1994-06-16
EP0606044A1 (en) 1994-07-13
TW258736B (enExample) 1995-10-01
GB9225396D0 (en) 1993-01-27

Similar Documents

Publication Publication Date Title
FI933258L (fi) Gelade organiska vaetskor
FI935803L (fi) Orgaanisten yhdisteiden hajottaminen
FI943876A0 (fi) Heterobisykliset yhdisteet
DK154192D0 (da) Heterocycliske forbindelser
FI950016A7 (fi) Heterosykliset yhdisteet lääkeaineena
FI935525A7 (fi) Slumpvis aotkomst i ett mobiltelefonsystem
FI933250A7 (fi) Hoeghastighets facilitetskydd i ett digitalt telekommunikationssystem
FI933251A7 (fi) Gruppfacilitetskydd i ett digitalt telekommunikationssystem
FI954768A0 (fi) Välituotteina käyttökelpoiset 4-syklopropyylimetoksipyridiiniyhdisteet
DK593088D0 (da) Organiske forbindelser
FI935409A7 (fi) Orgaanisiin yhdisteisiin liittyviä parannuksia
FI924768L (fi) Acetylenfoereningar
MX9205938A (es) Compuestos de di-ter-butilfenol utiles como agentes antiinflamatorios
FI970279A7 (fi) Orgaanisia yhdisteitä
GR1002188B (en) Improvements relating to organic compounds
FI933463L (fi) Slagutbredningspinne foer foerankring i ett cylindriskt borrhaol
FI882238A7 (fi) Orgaanisiin yhdisteisiin liittyviä parannuksia
DE68928648D1 (de) Organische Fluorverbindungen
NO930791D0 (no) Substituerte tinnsilikatforbindelser
FI920668A7 (fi) Oksatsinobentsatsoliyhdisteet
ITRM940566A0 (it) Composti organici
FI943637A7 (fi) Aryylialkoksifenoksi-imidatsoliiniyhdisteitä
FI923487A7 (fi) A87689-yhdisteitä
GB9200748D0 (en) Improvements relating to organic compounds
GB9115200D0 (en) Improvements relating to organic compounds

Legal Events

Date Code Title Description
FD Application lapsed